Intravitreal Aflibercept Injection (IAI)
VGFTe-AMD-1124
Approved small_molecule completed
Quick answer
Intravitreal Aflibercept Injection (IAI) for Age - Related Macular Degeneration (AMD) is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Age - Related Macular Degeneration (AMD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed